Our partner is focused on developing gene therapies to treat rare and inherited diseases. Using cutting-edge technology, they aim to address the root causes of genetic disorders and offer transformative solutions that improve patient outcomes and quality of life.

This critical hire contributed towards development, registration, life cycle support, as well as CMC regulatory strategy. They were a key interface between the Regulatory and the Technical Operations functions, to create and implement CMC regulatory strategies for CTA submission and marketing applications.